Study of the efficacy of a single 600 µg oral misoprostol dose for full uterine evacuation in cases of blighted ovum and missed abortions

Swapnali Kolekar; Amol Pawar

doi:10.18203/2320-6012.ijrms20263497

Authors

Swapnali Kolekar Department of Obstetrics and Gynecology, Government Medical College and Hospital Miraj, Sangli, Maharashtra, India
Amol Pawar Department of Obstetrics and Gynecology, Government Medical College and Hospital Miraj, Sangli, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20263497

Keywords:

Misoprostol, Miscarriage, Blighted ovum, Termination of pregnancy, Amenorrhoea

Abstract

Background: Missed abortions are common and represent a signifiant gynaecological emergency workload. The conventional method of uterus evacuation by vacuum aspiration is associated with morbidity and mortality. The search for a non-invasive method with high success rate and patient acceptability has led to the use of prostaglandins in varied conditions.

Methods: Present study was conducted with 50 cases. Patients who complained of amenorrhoea lasting fewer than 12 weeks and had ultrasonographic evidence of blighted ovum and/or missed abortions were included in this prospective trial. The study comprised patients who had been diagnosed with blighted ovum or missed abortion by ultrasonography, had amenorrhoea for fewer than 12 weeks, and were willing to receive medical treatment. The trial excluded patients with undiagnosed vaginal bleeding, amenorrhoea lasting longer than 12 weeks, incomplete or inevitable abortion, asthma, a history of medication responses to prostaglandins, signs of pelvic infection and/or sepsis, haemodynamic instability, or shock.

Results: 24.8 years mean maternal age and 8.4 weeks mean gestational age was observed. 56% cases were observed with surgical evacuation. Most of the cases i.e. 84% cases were seen with lower abdominal pain. Statistically no significant difference was observed in Hb.

Conclusions: When treating a blighted ovum with oral misoprostol 600 µg, their efficacy is nearly the same. Oral misoprostol is a useful treatment for blighted ovum.

References

Davis AR, Robilotto CM, Westhoff CL, Forman S, Zhang J, Nansel T, et al. Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure. Hum Reprod. 2004;19(7):1655-8.

Ramsey PS, Savage K, Lincoln T, Owen J. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Obstet Gynecol. 2004;104(1):138-45.

Chia KV, Ogbo VI. Medical termination of missed abortion. J Obstet Gynaecol. 2002;22(2):184-6.

Graziosi GC, Mol BW, Reuwer PJ, Drogtrop A, Bruinse HW. Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Hum Reprod. 2004;19(8):1894-9.

Chong YS, Su LL, Arulkumaran S. Misoprostol: a quarter century of use, abuse, and creative misuse. Obstet Gynecol Surv. 2004;59(2):128-40.

Grønlund A, Grønlund L, Clevin L, Andersen B, Palmgren N, Lidegaard Ø. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark. Acta Obstet Gynecol Scand. 2002;81(11):1060-5.

Coughlin LB, Roberts D, Haddad NG, Long A. Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective? J Obstet Gynaecol. 2004;24(1):69-71.

Pongsatha S, Tong Song T. Therapeutic termination of second trimester pregnancies with intrauterine foetal death with 400 microgram of misoprostol. J Obstet Gynaecol Res 2004; 30: 217-20.

Ayres-de-Campos D, Teixeira-da-Silva J, Campos I, Patrício B. Vaginal misoprostol in the management of first-trimester missed abortions. Int J Gynaecol Obstet. 2000;71(1):53-7.

Lemmers M, Verschoor MAC, Kim BV, Hickey M, Vazquez JC, Mol BWJ, et al. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database Syst Rev. 2019;6(6).

Gemzell-Danielsson K, Ho PC, Gómez Ponce de León R, Weeks A, Winikoff B. Misoprostol to treat missed abortion in the first trimester. Int J Gynaecol Obstet. 2007;99 Suppl 2.

Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 1999.

Ankum WM, Wieringa-De Waard M, Bindels PJ. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ. 2001;322(7298):1343-6.

Christin-Maitre S, Bouchard P, Spitz IM. Medical termination of pregnancy. N Engl J Med. 2000;342(13):946-56.

World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. BJOG. 2000;107(4):524-30.

Murchison A, Duff P. Misoprostol for uterine evacuation in patients with early pregnancy failures. Am J Obstet Gynecol. 2004;190(5):1445-6.

Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM; National Institute of Child Health and Human Development (NICHD) Management of Early Pregnancy Failure Trial. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005;353(8):761-9.

Ghosh J, Papadopoulou A, Devall AJ, Jeffery HC, Beeson LE, Do V, et al. Methods for managing miscarriage: a network meta-analysis. Cochrane Database of Systematic Reviews. 2021;6:CD012602.

Wagaarachchi PT, Ashok PW, Narvekar N, Smith NC, Templeton A. Medical management of early fetal demise using a combination of mifepristone and misoprostol. Hum Reprod. 2001;16(9):1849-53.

Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99 Suppl 2.

Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet. 2013;121(2):186-9.

American College of Obstetricians and Gynecologists. Practice Bulletin No. 150: early pregnancy loss. Obstet Gynecol. 2015;125(5):1258-67.

National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. London: NICE; 2012. Available from: https://www.nice.org.uk/guidance/cg154. Accessed on 25 April 20206.

Kollitz KM, Meyn LA, Lohr PA, Creinin MD. Mifepristone and misoprostol for early pregnancy failure: a cohort analysis. Am J Obstet Gynecol. 2011;204(5):386.e1-6.

Chu JJ, Devall AJ, Beeson LE, Hardy P, Cheed V, Sun Y, et al. Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;396(10253):770-8.

Schreiber CA, Creinin MD, Atrio J, Sonalkar S, Ratcliffe SJ, Barnhart KT. Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl J Med. 2018;378(23):2161-70.

Schreiber CA, Creinin MD, Reeves MF, Harwood BJ. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial. Contraception. 2006;74(6):458-62.

Sinha P, Suneja A, Guleria K, Aggarwal R, Vaid NB. Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy failure: a randomized double-blind placebo-controlled trial. J Obstet Gynaecol India. 2018;68(1):39-44.

Stockheim D, Machtinger R, Wiser A, Dulitzky M, Soriano D, Goldenberg M, et al. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure. Fertil Steril. 2006;86(4):956-60.